Clinical Trial Detail

NCT ID NCT03941964
Title A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

Therapies

Decitabine + Venetoclax

Azacitidine + Venetoclax

Age Groups: adult child senior

No variant requirements are available.